Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cardiovascular Diabetology|July 4, 2012
Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinideLisa Kitasato, Taiki Tojo, Yuko Hatakeyama, et al.
European Journal of Cardiovascular Nursing|June 7, 2022
Association between instrumental activities of daily living frequency and clinical outcomes in older patients with cardiovascular diseaseHidenori Kariya, Minako Yamaoka-Tojo, Nobuaki Hamazaki, et al.
Scientific Reports|December 29, 2025
Canagliflozin restores electrical properties and suppresses structural damage in isoproterenol-induced myocardial injury modelsLisa Kitasato, Yusuke Murayama, Naruya Ishizue, et al.
International Heart Journal|June 20, 2014
Factor Xa in mouse fibroblasts may induce fibrosis more than thrombinLisa Kitasato, Minako Yamaoka-Tojo, Takehiro Hashikata, et al.
ACS Biomaterials Science & Engineering|January 18, 2021
Design of Functional Electrospun Scaffolds Based on Poly(glycerol sebacate) Elastomer and Poly(lactic acid) for Cardiac Tissue EngineeringFlorence Flaig, Hélène Ragot, Alexandre Simon, et al.
Heart and Vessels|November 3, 2014
Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography studyTakehiro Hashikata, Taiki Tojo, Sayaka Namba, et al.
International Heart Journal|June 19, 2013
Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevationRyo Kameda, Minako Yamaoka-Tojo, Akihiro Makino, et al.
International Heart Journal|September 16, 2015
Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB PathwayTakehiro Hashikata, Minako Yamaoka-Tojo, Sayaka Namba, et al.
BBA Clinical|December 18, 2015
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosisSayaka Namba, Minako Yamaoka-Tojo, Takehiro Hashikata, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2015
Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)Lisa Kitasato, Takao Shimohama, Yuki Ikeda, et al.
Pageof 2